Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy.

@article{Gennep2017ComparisonOH,
  title={Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy.},
  author={Sara van Gennep and Saloomeh Sahami and Christianne Buskens and Gijs van den Brink and Cyriel Y. Ponsioen and Andr{\'e} D'Hoore and A de Buck van Overstraeten and Gert Van Assche and Marc Ferrante and S{\'e}verine Vermeire and Willem A. Bemelman and G D'Haens and Mark L{\"o}wenberg},
  journal={European journal of gastroenterology & hepatology},
  year={2017},
  volume={29 3},
  pages={338-344}
}
BACKGROUND AND AIMS Health-related quality of life (HRQL) and disability were compared in ulcerative colitis (UC) patients who underwent restorative proctocolectomy versus patients who received treatment with anti-tumor necrosis factor (anti-TNF) agents. PATIENTS AND METHODS UC patients who underwent restorative proctocolectomy or started anti-TNF treatment between January 2010 and January 2015 were included at two tertiary referral centers. A matched cohort was created using propensity score… CONTINUE READING